Growth and endocrine function in prepubertal children with asthma
Growth and endocrine function in prepubertal children with asthma
I measured growth velocity over 12 months at three monthly intervals in 56 prepubertal children with well controlled asthma who were grouped according to treatment (13 non-steroid, 19 inhaled budesonide, 20 inhaled beclomethasone, 4 inhaled steroid and prednisolone).
The results of the study showed that growth delay is a feature of asthma, irrespective of treatment, and is associated with reduced serum levels of the adrenal androgen dehydroepiandrosterone sulphate. Inhaled steroid treatment was associated with reduced linear growth velocity and this was more apparent in children taking beclomethasone dry powder compared with children taking budesonide through a nebuhaler. Increased oropharyngeal deposition and gastrointestinal absorption with the dry powder device may have accounted for this effect. The growth retarding effect of inhaled budesonide delivered through a nebuhaler was dose related and slow growth was likely in doses exceeding 1970 μg/m2/day. Growth rate correlated well with measures of adrenal gland function in particular, the rise in serum cortisol concentration in response to low-dose ACTH(1-24). Growth hormone (GH) secretion, serum IGF-1, IGF-1 bioactivity and IGF binding protein-3 were not affected by inhaled steroid treatment. However, the ratio of GH to its binding protein (BP) was reduced in children taking inhaled steroids and correlated with growth rate. GHBP correlated well with skinfold thickness, dietary intake of fat and carbohydrate and body mass index and may serve as a nutritional marker. There was a tendency for fasting levels of plasma insulin to be elevated by inhaled steroid treatment despite normoglycaemia. Types I and III collagen synthesis was reduced in children treated with inhaled steroids but type I collagen degradation appeared to be more active in non-steroid treated children and reduced by inhaled steroid treatment. These findings indicate that treatment of prepubertal asthmatic children with inhaled steroids may be accompanied by significant effects on growth, adrenal function and types I and III collagen metabolism.
University of Southampton
Crowley, Suzanne
41080327-ab5c-4a5d-8770-37d55278c130
1997
Crowley, Suzanne
41080327-ab5c-4a5d-8770-37d55278c130
Crowley, Suzanne
(1997)
Growth and endocrine function in prepubertal children with asthma.
University of Southampton, Doctoral Thesis.
Record type:
Thesis
(Doctoral)
Abstract
I measured growth velocity over 12 months at three monthly intervals in 56 prepubertal children with well controlled asthma who were grouped according to treatment (13 non-steroid, 19 inhaled budesonide, 20 inhaled beclomethasone, 4 inhaled steroid and prednisolone).
The results of the study showed that growth delay is a feature of asthma, irrespective of treatment, and is associated with reduced serum levels of the adrenal androgen dehydroepiandrosterone sulphate. Inhaled steroid treatment was associated with reduced linear growth velocity and this was more apparent in children taking beclomethasone dry powder compared with children taking budesonide through a nebuhaler. Increased oropharyngeal deposition and gastrointestinal absorption with the dry powder device may have accounted for this effect. The growth retarding effect of inhaled budesonide delivered through a nebuhaler was dose related and slow growth was likely in doses exceeding 1970 μg/m2/day. Growth rate correlated well with measures of adrenal gland function in particular, the rise in serum cortisol concentration in response to low-dose ACTH(1-24). Growth hormone (GH) secretion, serum IGF-1, IGF-1 bioactivity and IGF binding protein-3 were not affected by inhaled steroid treatment. However, the ratio of GH to its binding protein (BP) was reduced in children taking inhaled steroids and correlated with growth rate. GHBP correlated well with skinfold thickness, dietary intake of fat and carbohydrate and body mass index and may serve as a nutritional marker. There was a tendency for fasting levels of plasma insulin to be elevated by inhaled steroid treatment despite normoglycaemia. Types I and III collagen synthesis was reduced in children treated with inhaled steroids but type I collagen degradation appeared to be more active in non-steroid treated children and reduced by inhaled steroid treatment. These findings indicate that treatment of prepubertal asthmatic children with inhaled steroids may be accompanied by significant effects on growth, adrenal function and types I and III collagen metabolism.
This record has no associated files available for download.
More information
Published date: 1997
Identifiers
Local EPrints ID: 463267
URI: http://eprints.soton.ac.uk/id/eprint/463267
PURE UUID: e85548aa-af5c-408f-997d-2670c4347ff9
Catalogue record
Date deposited: 04 Jul 2022 20:48
Last modified: 04 Jul 2022 20:48
Export record
Contributors
Author:
Suzanne Crowley
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics